NCT00316186 - First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

March 31, 2009

Study Completion Date

May 31, 2009

Conditions

Lung Cancer, Small Cell

Interventions

DRUG

topotecan

Hycamtin and Carboplatin as first-line treatment of chemonaive subjects with EX-SCLC.

DRUG

carboplatin

Hycamtin and Carboplatin as first-line treatment of chemonaive subjects with EX-SCLC.

Trial Locations (13)

GSK Investigational Site, The Bronx

GSK Investigational Site, Richmond

GSK Investigational Site, Hollywood

GSK Investigational Site, Boca Raton

GSK Investigational Site, Munster

GSK Investigational Site, Chicago

GSK Investigational Site, St Louis

GSK Investigational Site, Metairie

GSK Investigational Site, Amarillo

GSK Investigational Site, Tucson

GSK Investigational Site, Concord

GSK Investigational Site, Sacramento

GSK Investigational Site, Poznan